Innovative ETFs Channel Biotech ETFs Are Breaking Out on Pfizer’s Array Biopharma Deal By Max ChenJune 17, 2019
Leveraged & Inverse Channel Direxion to Change Indexes For Leveraged Pharma, Real Estate ETFs By Todd ShriberJune 4, 2019
Leveraged & Inverse Channel Everything That You Wanted To Ask About Investing In Pharma Stocks By ETF TrendsApril 18, 2019
Beyond Basic Beta Channel 4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat By Ben HernandezApril 9, 2019
Innovative ETFs Channel Pharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug Results By Max ChenFebruary 28, 2019
Leveraged & Inverse Channel Big Biopharma Mergers Could Fuel These ETFs in 2019 By Ben HernandezJanuary 10, 2019
Leveraged & Inverse Channel Pharma Earnings: The PILL to CURE Market Troubles? By DirexionNovember 1, 2018
